Factors affecting hospital length of stay following pelvic exenteration surgery

J Surg Oncol. 2018 Mar;117(3):529-534. doi: 10.1002/jso.24878. Epub 2017 Oct 16.

Abstract

Background and objectives: Total pelvic exenteration are performed in patients with locally advanced or recurrent pelvic malignances. Many patients have prolong hospital length of stay (LOS), but risk factors are not clearly identified.

Methods: From 2002 through 2012, 100 consecutive patients undergoing pelvic exenteration were retrospectively reviewed. A general linear model was used to examine risk factors for prolonged hospital LOS.

Results: Among the 100 patients, 51 had gastrointestinal cancer, 14 had genitourinary cancer, 31 had gynecologic cancer, and 4 had sarcoma. Perioperative complications included infection (n = 44), anastomotic leak/fistula (n = 6), wound or flap dehiscence (n = 11), and ileus or bowel obstruction (n = 30). The median (Interquartile range (IQR)) hospital LOS was 15 days (10-21.5 days). On multivariate regression analysis, hospital LOS was significantly prolonged by underweight status, genitourinary cancer or sarcoma diagnosis, ≥2 infections, anastomotic leak/fistula, requiring rehabilitation consult and admission, and ≥2 consultations (P = 0.05).

Conclusion: In patients undergoing pelvic exenteration, prolonged hospital LOS is associated with underweight status, genitourinary cancer or sarcoma diagnosis, more than one infection, anastomotic leak/fistula, requiring rehabilitation consult and admission, and more than one consultation. Further study is needed to assess whether minimizing these risk factors can improve hospital LOS in these patients.

Keywords: cancer; hospital length of stay; pelvic exenteration.

MeSH terms

  • Female
  • Gastrointestinal Neoplasms / surgery
  • Genital Neoplasms, Female / surgery
  • Humans
  • Length of Stay
  • Male
  • Middle Aged
  • Neoplasms / surgery*
  • Pelvic Exenteration / methods*
  • Retrospective Studies